Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia

Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the Medical Therapy of Prostatic Symptoms (MTOPS) Study

(2019) Jill A. Macoska et al.   JOURNAL OF UROLOGY

Synthesis of a Cleaved Form of Osteopontin by THP-1 Cells and Its Alteration by Phorbol 12-Myristate 13-Acetate and BCG Infection

(2018) Gaowa Bai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis

(2018) Petra Popovics et al.   PROSTATE

Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt

(2018) Tu Dang et al.   Scientific Reports

Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis

(2018) Guangying Cui et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Multidimensional pooled shRNA screens in human THP-1 cells identify candidate modulators of macrophage polarization

(2017) Ewa Surdziel et al.   PLoS One

Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells

(2017) Petra Popovics et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia

(2016) Magdalena M. Grabowska et al.   ENDOCRINOLOGY

Low expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure

(2016) Ruonan Xu et al.   Scientific Reports

Characterization of autoimmune inflammation induced prostate stem cell expansion

(2015) Hsing-Hui Wang et al.   PROSTATE

NF-κB and androgen receptor variant expression correlate with human BPH progression

(2015) David C. Austin et al.   PROSTATE

CXCL5 Promotes Prostate Cancer Progression

(2015) Lesa A Begley et al.   NEOPLASIA

Osteopontin binds multiple calcium ions with high affinity and independently of phosphorylation status

(2014) Eva Kläning et al.   BONE

Osteopontin mediates an MZF1–TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer

(2014) C E Weber et al.   ONCOGENE

Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network

(2014) Opal Lin-Tsai et al.   PROSTATE

Is Transforming Growth Factor-βSignaling Activated in Human Hypertrophied Prostate Treated by 5-Alpha Reductase Inhibitor?

(2013) Hye Kyung Kim et al.   DISEASE MARKERS

Osteopontin delays resolution of liver fibrosis

(2013) Tung-Ming Leung et al.   LABORATORY INVESTIGATION

Prostatic fibrosis, lower urinary tract symptoms and BPH

(2013) Jose A. Rodriguez-Nieves et al.   Nature Reviews Urology

Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways

(2012) E.R. Gimba et al.   CANCER LETTERS

Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis

(2012) Minghua Wu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Prostatic Fibrosis is Associated with Lower Urinary Tract Symptoms

(2012) Jinjin Ma et al.   JOURNAL OF UROLOGY

Fibrosis-related gene expression in the prostate is modulated by doxazosin treatment

(2012) Flávia K. Delella et al.   LIFE SCIENCES

CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis

(2012) Mehrnaz Gharaee-Kermani et al.   PLoS One

Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis

(2012) Satoshi Ueha et al.   Frontiers in Immunology

Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia

(2011) T.M. Tilli et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Osteopontin-Stimulated Expression of Matrix Metalloproteinase-9 Causes Cardiomyopathy in the mdx Model of Duchenne Muscular Dystrophy

(2011) S. Dahiya et al.   JOURNAL OF IMMUNOLOGY

Intracellular osteopontin (iOPN) and immunity

(2010) Makoto Inoue et al.   IMMUNOLOGIC RESEARCH

Osteopontin is a tumor autoantigen in prostate cancer patients

(2010) TATIANA M. TILLI et al.   Oncology Letters

Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1

(2009) Ira Kogan-Sakin et al.   CARCINOGENESIS

Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation

(2009) G. Penna et al.   JOURNAL OF IMMUNOLOGY

Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis

(2009) Grégoire Robert et al.   PROSTATE

Functional Remodeling of Benign Human Prostatic Tissues In Vivo by Spontaneously Immortalized Progenitor and Intermediate Cells

(2009) Ming Jiang et al.   STEM CELLS

Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression

(2008) G. Castellano et al.   CLINICAL CANCER RESEARCH

Osteopontin: Role in immune regulation and stress responses

(2008) Kathryn X. Wang et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring

(2008) Ryoichi Mori et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA

(2008) Jill A. Macoska et al.   PROSTATE

Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model

(2008) Isaiah G. Schauer et al.   PROSTATE

Prevalence and Characteristics of Lower Urinary Tract Symptoms in Men Aged ≥80 Years

(2008) J. Kellogg Parsons et al.   UROLOGY